Nissay Asset Management Corp Regeneron Pharmaceuticals, Inc. Transaction History

Nissay Asset Management Corp

  • $16.7 Billion
  • Q2 2025

A detailed history of Nissay Asset Management Corp transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Nissay Asset Management Corp holds 26,956 shares of REGN stock, worth $17.6 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
26,956
Previous 26,417 2.04%
Holding current value
$17.6 Million
Previous $16.8 Million 15.54%
% of portfolio
0.08%
Previous 0.11%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
BUY
$483.07 - $625.6 $260,374 - $337,198
539 Added 2.04%
26,956 $14.2 Million
Q1 2025

May 15, 2025
BUY
$634.14 - $744.83 $1.45 Million - $1.71 Million
2,292 Added 9.5%
26,417 $16.8 Million
Q4 2024

Feb 14, 2025
BUY
$701.85 - $1046.91 $594,466 - $886,732
847 Added 3.64%
24,125 $17.2 Million
Q3 2024

Nov 14, 2024
BUY
$1024.09 - $1201.76 $1.97 Million - $2.31 Million
1,921 Added 8.99%
23,278 $24.5 Million
Q2 2024

Aug 14, 2024
BUY
$883.2 - $1071.19 $2.12 Million - $2.57 Million
2,397 Added 12.64%
21,357 $22.4 Million
Q1 2024

May 15, 2024
BUY
$902.69 - $993.35 $3.88 Million - $4.27 Million
4,295 Added 29.29%
18,960 $18.2 Million
Q4 2023

Feb 14, 2024
BUY
$775.18 - $881.7 $579,834 - $659,511
748 Added 5.37%
14,665 $12.9 Million
Q3 2023

Nov 14, 2023
BUY
$692.45 - $844.37 $610,740 - $744,734
882 Added 6.77%
13,917 $11.5 Million
Q2 2023

Aug 14, 2023
SELL
$700.03 - $830.35 $8,400 - $9,964
-12 Reduced 0.09%
13,035 $9.37 Million
Q1 2023

May 15, 2023
SELL
$680.49 - $826.97 $283,083 - $344,019
-416 Reduced 3.09%
13,047 $10.7 Million
Q4 2022

Feb 14, 2023
SELL
$705.89 - $766.39 $566,829 - $615,411
-803 Reduced 5.63%
13,463 $9.71 Million
Q3 2022

Nov 14, 2022
BUY
$573.97 - $724.32 $321,423 - $405,619
560 Added 4.09%
14,266 $9.83 Million
Q2 2022

Aug 15, 2022
BUY
$548.35 - $738.84 $307,076 - $413,750
560 Added 4.26%
13,706 $8.1 Million
Q1 2022

May 16, 2022
BUY
$595.12 - $698.43 $163,062 - $191,369
274 Added 2.13%
13,146 $9.18 Million
Q4 2021

Feb 14, 2022
BUY
$543.48 - $670.97 $234,239 - $289,188
431 Added 3.46%
12,872 $8.13 Million
Q3 2021

Nov 10, 2021
SELL
$574.03 - $680.96 $210,094 - $249,231
-366 Reduced 2.86%
12,441 $7.53 Million
Q2 2021

Aug 13, 2021
SELL
$472.8 - $558.54 $198,576 - $234,586
-420 Reduced 3.18%
12,807 $7.15 Million
Q1 2021

May 11, 2021
SELL
$446.73 - $548.2 $141,613 - $173,779
-317 Reduced 2.34%
13,227 $6.26 Million
Q4 2020

Feb 08, 2021
BUY
$478.3 - $607.98 $291,763 - $370,867
610 Added 4.72%
13,544 $6.54 Million
Q3 2020

Oct 20, 2020
SELL
$544.75 - $658.21 $264,748 - $319,890
-486 Reduced 3.62%
12,934 $7.24 Million
Q2 2020

Jul 27, 2020
SELL
$493.32 - $643.92 $5.12 Million - $6.68 Million
-10,373 Reduced 43.6%
13,420 $8.37 Million
Q1 2020

May 05, 2020
SELL
$336.18 - $494.43 $5.01 Million - $7.37 Million
-14,913 Reduced 38.53%
23,793 $11.6 Million
Q4 2019

Feb 14, 2020
SELL
$274.13 - $376.51 $664,491 - $912,660
-2,424 Reduced 5.89%
38,706 $14.5 Million
Q3 2019

Nov 14, 2019
BUY
$273.46 - $318.39 $1.74 Million - $2.02 Million
6,347 Added 18.25%
41,130 $11.4 Million
Q2 2019

Aug 07, 2019
SELL
$299.6 - $414.82 $368,208 - $509,813
-1,229 Reduced 3.41%
34,783 $10.9 Million
Q1 2019

May 03, 2019
SELL
$372.08 - $439.57 $371,335 - $438,690
-998 Reduced 2.7%
36,012 $14.8 Million
Q4 2018

Feb 06, 2019
BUY
$335.82 - $403.04 $129,626 - $155,573
386 Added 1.05%
37,010 $13.8 Million
Q3 2018

Oct 30, 2018
BUY
$351.14 - $408.51 $855,377 - $995,130
2,436 Added 7.13%
36,624 $14.8 Million
Q2 2018

Aug 08, 2018
BUY
$284.6 - $344.99 $1.7 Million - $2.06 Million
5,957 Added 21.1%
34,188 $11.8 Million
Q1 2018

May 14, 2018
BUY
$315.82 - $393.78 $1.53 Million - $1.91 Million
4,856 Added 20.77%
28,231 $9.72 Million
Q4 2017

Feb 14, 2018
BUY
$358.63 - $469.95 $8.38 Million - $11 Million
23,375
23,375 $8.79 Million

Others Institutions Holding REGN

# of Institutions
1,437
Shares Held
88.9M
Call Options Held
1.98M
Put Options Held
1.75M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $70.1B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Nissay Asset Management Corp Portfolio

Follow Nissay Asset Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nissay Asset Management Corp , based on Form 13F filings with the SEC.

News

Stay updated on Nissay Asset Management Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email